Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2010
02/09/2010US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure
02/09/2010US7659371 Patched polypeptides and uses related thereto
02/09/2010US7659258 A DNA segment with amino acid, phosphorothioate or phosphoroamidate linkages capable of modifying the molecular phenotype of osteoclasts and increasing the expression of the oestrogen alpha receptor gene; osteoporosis, periodontal disease, Paget's Disease, Antiarthritic agents; breast and prostate cancer
02/09/2010US7659121 culturing human salivary gland cells in vitro to obtain human stem cells which are nestin-positive and albumin-positive, differentiating the stem cells by culture in vitro to induce insulin-positive cells; regenerative therapy; transplant rejection
02/09/2010US7659120 Δ 15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
02/09/2010US7659119 Method and compositions for obtaining mature dendritic cells
02/09/2010US7659118 Multipotent adult stem cells
02/09/2010US7659117 Immunostimulatory fusion proteins comprising polypeptide antigen for generating protective DC-induced T-cell-mediated immune responses; metastatic cancers
02/09/2010US7659116 Monoclonal antibody against frizzled receptor 4
02/09/2010US7659115 Nucleic acid encoding human transductin-1 polypeptide
02/09/2010US7659113 Delivery system
02/09/2010US7659103 Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
02/09/2010US7659094 Nucleic acid sequences having gene transcription regulatory qualities
02/09/2010US7659082 Utilizing SCN9A (sodium channel alpha subunits) gene and expression products thereof for the screening and identification of therapeutic agents; in vitro method for identifying a selective inhibitor of human SCN9A
02/09/2010US7658951 Method of improving cardiac function of a diseased heart
02/09/2010US7658934 Chlamydia antigens and protein vaccine
02/09/2010US7658931 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection
02/09/2010US7658926 Autologous T-cell vaccines materials and methods
02/09/2010US7658915 Selected cell delivery for heart failure
02/09/2010US7658341 Dispersion devices for aggregates
02/09/2010CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells
02/09/2010CA2453218C Allene oxide synthase and divinyl ether synthase from cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method forproducing pathogen-resistant plants
02/09/2010CA2407112C Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
02/09/2010CA2372666C Methods for predicting pregnancy outcome in a subject by hcg assay
02/09/2010CA2349875C Dna encoding a growth factor specific for epithelial cells
02/09/2010CA2286614C Plant extracts for the treatment of increased bone resorption
02/09/2010CA2205910C Plasmids suitable for il-2 expression
02/04/2010WO2010014949A2 Compositions comprising hepatocyte-like cells and uses thereof
02/04/2010WO2010014675A1 Neural stem cell isolates from the dental papillary annulus of developing teeth
02/04/2010WO2010014622A2 In vitro model for modulating the blood brain barrier and methods of screening
02/04/2010WO2010013947A2 Growth method for natural killer cells
02/04/2010WO2010013906A2 Method for separating highly active stem cells from human stem cells and highly active stem cells separated thereby
02/04/2010WO2010013845A1 Method of efficiently establishing induced pluripotent stem cells
02/04/2010WO2010013830A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same
02/04/2010WO2010013767A1 Novel protease and use thereof
02/04/2010WO2010013485A1 Melk epitope peptides and vaccines containing the same
02/04/2010WO2010013359A1 Efficient method for establishing induced pluripotent stem cells
02/04/2010WO2010012948A2 Combination of two genetic elements for controlling the floral development of a dicotyledonous plant, and use in detection and selection methods
02/04/2010WO2010012829A1 Her2/neu specific t cell receptors
02/04/2010WO2010012077A1 Compositions, methods and kits for reprogramming somatic cells
02/04/2010WO2009068649A3 Antigen-binding constructs
02/04/2010WO2004099365A9 Transcription factor gene induced by water deficit conditions and abscisic acid from helianthus annuus, promoter and transgenic plants
02/04/2010WO2004070027A9 Method for modifying plant growth characteristics
02/04/2010WO2003076575A9 The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
02/04/2010US20100031400 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same
02/04/2010US20100031398 Genes encoding chavicol/eugenol synthase from the creosote bush larrea tridentata
02/04/2010US20100031397 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
02/04/2010US20100031396 and processing of transgenic sugarcane using a nucleic acid encoding the promoter of a Sugarcane Elongation Factor (SEF)
02/04/2010US20100031393 Novel protein having acyltransferase activity and gene encoding the same
02/04/2010US20100031392 Sugar and lipid metabolism regulators in plants vi
02/04/2010US20100031391 Antifungal polypeptides
02/04/2010US20100031390 Gibberellin 2-Oxidase
02/04/2010US20100031377 Prevention and treatment of synucleinopathic and amyloidogenic disease
02/04/2010US20100029764 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
02/04/2010US20100029751 Compositions comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis
02/04/2010US20100029674 Methods of Using Phosphoantigen for the Treatment of Cancer
02/04/2010US20100029613 Treatment and prevention of epilepsy
02/04/2010US20100029573 Tumor-associated peptides that bind to mhc-molecules
02/04/2010US20100029571 Novel and powerful mhc-class ii peptides derived from survivin
02/04/2010US20100029558 Alpha1 proteinase inhibitor peptides methods and use
02/04/2010US20100029547 Mvl, an antiviral protein from a cyanobacterium
02/04/2010US20100029489 Sucrose transport proteins
02/04/2010US20100029485 Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
02/04/2010US20100029484 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
02/04/2010US20100029481 Chimeric gene with several herbicide tolerance genes, plant cell and plant resistant to several herbicides
02/04/2010US20100029001 Rotating transfer for complex patterning
02/04/2010US20100029000 Assembly and methods for cell or tissue culture and treatment
02/04/2010US20100028999 Methods, apparatus, and systems for fabrication of polymeric nano- and micro-fibers in aligned configurations
02/04/2010US20100028998 modifying the expression of one or more genes by introducing to a cell, tissue, or organ of interest a 1-x RNAi expression cassette encoding x stem-loop structures; genetic engineering
02/04/2010US20100028997 Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis
02/04/2010US20100028996 Retroviral vectors for delivery of interfering rna
02/04/2010US20100028995 Tetranectin Trimerizing Polypeptides
02/04/2010US20100028994 Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
02/04/2010US20100028948 nucleic acids encoding antibodies which immunospecifically bind to one or more respiratory syncytial virus (RSV) antigens
02/04/2010US20100028947 Use of human cells of myeloid leukaemia origin for expression of antibodies
02/04/2010US20100028946 Fusion partner cells
02/04/2010US20100028942 Methods for Improving Viability and Productivity in Cell Culture
02/04/2010US20100028940 Compositions and Methods for Metabolic Selection of Transfected Cells
02/04/2010US20100028931 Neurodegenerative diseases and methods of modeling
02/04/2010US20100028929 encoding CD36, Gqi9, and G protein-coupled receptor 84 (GPR84) proteins; permits the screening for modulators of taste activity
02/04/2010US20100028913 Novel carbohydrate from human cells and methods for analysis and modification thereof
02/04/2010US20100028904 Way to obtain high expression clones of mammalian cells using a methylcellulose with fluorescent protein a or g and fluorescent screening method
02/04/2010US20100028902 Living cell force sensors and methods of using same
02/04/2010US20100028901 Method for diagnosing in vitro or ex vivo psychiatric disorders and/or intestinal dysbioses
02/04/2010US20100028899 Cell cycle phase markers
02/04/2010US20100028866 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Nato3
02/04/2010US20100028865 Method for Identifying Regulatory T Cells
02/04/2010US20100028852 Methods and reagents for preserving rna in cell and tissue samples
02/04/2010US20100028851 Multi-Lineage Progenitor Cells
02/04/2010US20100028460 Improvements in relation to cancer therapy
02/04/2010US20100028450 Tolerogenic biodegradable artificial antigen presenting system
02/04/2010US20100028445 Polymer
02/04/2010US20100028430 Material and manufacturing method of bioactive protein-calcium phosphate composite
02/04/2010US20100028418 Gainac specific binding molecules and uses thereof
02/04/2010US20100028387 Biocompatible Coated Nanostructured Titanium Surfaces
02/04/2010US20100028382 Lentival Vector-Based Vaccine
02/04/2010US20100028375 Vlp based vaccine delivery system
02/04/2010US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
02/04/2010US20100028373 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
02/04/2010US20100028367 Sgp130/fc dimers